Because androgen-independent prostate cancers often become resistant to antiandrogens, we tested the effect of the antiandrogen flutamide on DHT-stimulated PSA mRNA levels in control and CAsE-PE cells. This evidence concerns the gene KLK3 and prostate carcinoma.